Deficiency of respiratory chain complex I is a common cause of leigh disease
暂无分享,去创建一个
D. Turnbull | G. Brown | B. Harding | J. Bell | A. Harding | C. Woodward | L. Bindoff | J. Leonard | M. Farrell | B. Lake | A. Morris | D. Morris | M. Mirakhur | S. K. Bidouki | PhD A. A. M. Morris | PhD J. V. Leonard | PhD G. K. Brown | BSc S. K. Bidouki | MD L. A. Bindoff | MD S A. E. Harding | PhD T B. D. Lake | DPhil B. N. Harding | FRCPathtt M. A. Farrell | MD J. E. Bell | Mdqq M. Mirakhur | PhD D. M. Turnbull
[1] Dominic Thyagarajan,et al. A novel mitochondrial ATPase 6 point mutation in familial bilateral striatal necrosis , 1995, Annals of neurology.
[2] B. Harding,et al. Pathogenic factors underlying the lesions in Leigh's disease. Tissue responses to cellular energy deprivation and their clinico-pathological consequences. , 1994, Brain : a journal of neurology.
[3] A. Harding,et al. Mitochondrial DNA 8993 (NARP) mutation presenting with a heterogeneous phenotype including 'cerebral palsy'. , 1994, Archives of disease in childhood.
[4] D. Gadian,et al. Clinical diversity of pyruvate dehydrogenase deficiency. , 1994, Pediatric neurology.
[5] S. Dimauro,et al. A T → C mutation at nt 8993 of mitochondrial DNA in a child with Leigh syndrome , 1994, Neurology.
[6] D. Turnbull,et al. An evaluation of the measurement of the activities of complexes I-IV in the respiratory chain of human skeletal muscle mitochondria. , 1994, Biochemical medicine and metabolic biology.
[7] C. R. Kennedy,et al. Mitochondrial DNA mutation underlying Leigh's syndrome: Clinical, pathological, biochemical, and genetic studies of a patient presenting with progressive myoclonic epilepsy , 1994, Journal of the Neurological Sciences.
[8] S. Dimauro,et al. The mutation at nt 8993 of mitochondrial DNA is a common cause of Leigh's syndrome , 1993, Annals of neurology.
[9] G. Brown,et al. Molecular genetic characterization of an X‐linked form of Leigh's syndrome , 1993, Annals of neurology.
[10] R. Sakuta,et al. Leigh encephalopathy: histologic and biochemical analyses of muscle biopsies. , 1992, Pediatric neurology.
[11] D. Turnbull,et al. Measurement of the activity of individual respiratory chain complexes in isolated fibroblast mitochondria. , 1992, Analytical biochemistry.
[12] D. Turnbull,et al. Leigh syndrome associated with a deficiency of the pyruvate dehydrogenase complex: results of treatment with a ketogenic diet. , 1992, Neuropediatrics.
[13] E. Holme,et al. Leber's hereditary optic neuropathy and complex I deficiency in muscle , 1991, Annals of neurology.
[14] S. Dimauro,et al. Cytochrome c oxidase-associated Leigh syndrome: Phenotypic features and pathogenetic speculations , 1991, Journal of the Neurological Sciences.
[15] S. Dimauro,et al. mtDNA depletion with variable tissue expression: a novel genetic abnormality in mitochondrial diseases. , 1991, American journal of human genetics.
[16] I. M. Shepherd,et al. Cytochrome oxidase deficiency: Immunological studies of skeletal muscle mitochondrial fractions , 1988, Journal of the Neurological Sciences.
[17] G. Brown,et al. Immunochemical analysis of normal and mutant forms of human pyruvate dehydrogenase. , 1986, The Biochemical journal.
[18] F. Gabreëls,et al. Disturbed oxidative metabolism in subacute necrotizing encephalomyelopathy (Leigh syndrome). , 1986, Neuropediatrics.
[19] F. Gabreëls,et al. Subacute necrotizing encephalomyelopathy (Leigh syndrome) associated with disturbed oxidation of pyruvate, malate and 2‐oxoglutarate in muscle and liver , 1985, Acta neurologica Scandinavica.
[20] M. Ito,et al. Complex I (reduced nicotinamide-adenine dinucleotide-coenzyme Q reductase) deficiency in two patients with probable Leigh syndrome. , 1990, The Journal of pediatrics.